Basingstoke, U. With Shire's experience as a leader in the development and commercialization of ADHD medications, we are confident that this approval for adult patients will help continue to increase prescription share and volume of VYVANSE. These symptoms can significantly impact them at work, home and in relationships, where they have important responsibilities," said David W.
Today, there are several options to treat ADHD. Stimulant medications, for example, increase levels of certain neurotransmitters brain chemicals to improve concentration and focus and to reduce hyperactive and impulsive behavior. Both drugs can be effective, but the differences in some of their features may make one of them a more appealing choice for you.
Vyvanse lisdexamfetamine dimesylate is an amphetamine derivative prodrug administered once-daily for the treatment of attention deficit hyperactivity disorder ADHD and binge-eating disorder. Vyvanse lisdexamfetamine dimesylate Consumer Information. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
It is not approved for weight losshowever, for people who have moderate-to-severe BED, treating the binge eating with Vyvanse can lead to weight loss. It involves recurring episodes of binge eating without purging and accompanying feelings of remorse afterward. Binge eating can lead to weight gain and ultimately obesity. It is defined as eating a significantly larger than normal portion of food in a short period and feeling that you cannot stop or control how much you are eating.
What is Vyvanse lisdexamfetamine? Vyvanse is a brand name prescription drug used to treat attention deficit hyperactivity disorder ADHD in children and adults, and binge eating disorder in adults. Vyvanse is a stimulant that affects the parts of the brain and central nervous system that control hyperactivity and impulses.
New River. Vyvanse is a pro-drug of dextroamphetamine. It works primarily by inducing the release of the neurotransmitters dopamine and norepinephrine from their storage areas in nerve terminals.
Binge eating disorder BED is the most common eating disorder and an important public health problem. It is characterized by recurrent episodes of excessive food consumption accompanied by a sense of loss of control over the binge eating behavior without the inappropriate compensatory weight loss behaviors of bulimia nervosa. BED affects both sexes and all age groups and is associated with medical and psychiatric comorbidities.
Lisdexamfetaminesold under the brand name Vyvanse among othersis a medication that is used to treat attention deficit hyperactivity disorder ADHD in people over the age of five as well as for moderate to severe binge eating disorder in adults. Common side effects of lisdexamfetamine include loss of appetite, anxiety, diarrhea, trouble sleepingirritability, and nausea. Lisdexamfetamine was approved for medical use in the United States in Lisdexamfetamine is used primarily as a treatment for attention deficit hyperactivity disorder ADHD and binge eating disorder ;  it has similar off-label uses as those of other pharmaceutical amphetamines.
Sharon, diagnosed with moderate B. Vyvanse is the first and only medication approved to treat moderate to severe Binge Eating Disorder B. Vyvanse is not for weight loss.
Vickers, PhD, global head of research and development at Shire, said in a press release. Philip J. Vickers The labeling will now include maintenance findings from a phase 3, week, multicenter, double-blind, placebo-controlled, randomized withdrawal study among adults aged 18 to 55 years with moderate-to-severe binge-eating disorder.